Showing results (171-180 of 1,348) with videos related to
Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|January 5, 2022
Pharmacokinetic Drug Interaction Between Raloxifene and Cholecalciferol in Healthy VolunteersHae Won Lee, Woo Youl Kang, Wookjae Jung, et al.Clinical Pharmacology in Drug Development|January 3, 2022
Population Pharmacokinetic Modeling and Exposure-Response Analysis for Aripiprazole Once Monthly in Subjects With SchizophreniaXiaofeng Wang, Arash Raoufinia, Sébastien Bihorel, et al.Clinical Pharmacology in Drug Development|December 30, 2021
Evaluating the Safety, Tolerability, and Disposition of Trazpiroben, a D2 /D3 Receptor Antagonist: Phase I Single- and Multiple-Ascending Dose Studies in Healthy Japanese ParticipantsTakayoshi Yamaguchi, Kentarou Kudou, Hiroyuki Okamoto, et al.Clinical Pharmacology in Drug Development|October 27, 2022
Safety, Pharmacokinetics, and Biomarkers of an Amorphous Solid Dispersion of Genistein, a Radioprotectant, in Healthy VolunteersArtur A Serebrenik, Carin W Verduyn, Michael D KaytorClinical Pharmacology in Drug Development|October 17, 2022
Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of Prasugrel in Healthy Male VolunteersMi-Jo Kim, Hyungsub Kim, Sang-Min Lee, et al.Clinical Pharmacology in Drug Development|October 26, 2022
Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF-07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS-CoV-2, in Healthy Adult ParticipantsTong Zhu, Sylvester Pawlak, Sima S Toussi, et al.Clinical Pharmacology in Drug Development|September 5, 2022
Drug-Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379 (Bersacapavir)Joris Vandenbossche, Jeysen Yogaratnam, Vera Hillewaert, et al.Clinical Pharmacology in Drug Development|November 1, 2022
A Randomized, Single-dose, Phase I Clinical Comparison of a Trastuzumab Biosimilar With a Reference Trastuzumab Formulation in Healthy Chinese Male VolunteersHuahua Pu, Jingying Jia, Chunyang Zhao, et al.Clinical Pharmacology in Drug Development|September 14, 2022
Pharmacokinetics and Safety of Vibegron 75 mg Administered as an Intact or Crushed Tablet in Healthy AdultsJennifer King, Ann Walker, Dorothy Aikin, et al.Clinical Pharmacology in Drug Development|September 1, 2022
Effect of Meal Timings and Meal Content on the AUC0-12h of Mycophenolic Acid: A Simulation StudyLixuan Qian, Zheng Jiao, Mingkang ZhongPageof 135